The risk of pulmonary embolism and deep vein thrombosis in rheumatoid arthritis: a UK population-based outpatient cohort study
- PMID: 22930596
- DOI: 10.1136/annrheumdis-2012-201669
The risk of pulmonary embolism and deep vein thrombosis in rheumatoid arthritis: a UK population-based outpatient cohort study
Abstract
Background: Recent hospital-based studies have suggested a sixfold increased risk of pulmonary embolism (PE) in rheumatoid arthritis (RA) in the year following admission. We evaluated the risk of PE and deep vein thrombosis (DVT) and associated time trend among RA patients (84.5% without a history of hospitalisation during the past year) derived from the general population.
Methods: We conducted a cohort study using an electronic medical records database representative of the UK general population, collected from 1986 to 2010. Primary definitions of the RA cohort (exposure) and PE/DVT outcomes required physician diagnoses followed by corresponding treatments. We estimated relative risks (RRs) of PE and DVT compared with a matched non-RA comparison cohort, adjusting for age, sex, smoking, body mass index, comorbidities and hospitalisations.
Results: Among 9589 individuals with RA (69% female, mean age of 58 years), 82 developed PE and 110 developed DVT (incidence rates, 1.5 and 2.1 per 1000 person-years). Compared with non-RA individuals (N=95 776), the age-, sex- and entry-time-matched RRs were 2.23 (95% CI 1.75 to 2.86) for PE and 2.20 (CI 1.78 to 2.71) for DVT. Adjusting for other covariates, the corresponding RRs were 2.16 (CI 1.68 to 2.79) and 2.16 (CI 1.74 to 2.69). The time-specific RRs for PE were 3.27, 1.88 and 2.35 for follow-up times of <1 year, 1-4.9 years, and ≥5 years, and corresponding RRs for DVT were 3.16, 1.82 and 2.32.
Conclusions: This population-based study indicates an increased risk of PE and DVT in RA, supporting increased monitoring of venous-thromboembolic complications and risk factors in RA, regardless of hospitalisation.
Keywords: Cardiovascular Disease; Inflammation; Rheumatoid Arthritis.
Similar articles
-
The risk and trend of pulmonary embolism and deep vein thrombosis in rheumatoid arthritis: a general population-based study.Rheumatology (Oxford). 2021 Jan 5;60(1):188-195. doi: 10.1093/rheumatology/keaa262. Rheumatology (Oxford). 2021. PMID: 32617563 Free PMC article.
-
Rheumatoid arthritis increases the risk of deep vein thrombosis and pulmonary thromboembolism: a nationwide cohort study.Ann Rheum Dis. 2014 Oct;73(10):1774-80. doi: 10.1136/annrheumdis-2013-203380. Epub 2013 Aug 7. Ann Rheum Dis. 2014. PMID: 23926057
-
Deep vein thrombosis and pulmonary embolism among hospitalized coronavirus disease 2019-positive patients predicted for higher mortality and prolonged intensive care unit and hospital stays in a multisite healthcare system.J Vasc Surg Venous Lymphat Disord. 2021 Nov;9(6):1361-1370.e1. doi: 10.1016/j.jvsv.2021.03.009. Epub 2021 Apr 6. J Vasc Surg Venous Lymphat Disord. 2021. PMID: 33836287 Free PMC article.
-
The incidence of deep venous thrombosis and pulmonary embolism among patients with inflammatory bowel disease: a population-based cohort study.Thromb Haemost. 2001 Mar;85(3):430-4. Thromb Haemost. 2001. PMID: 11307809
-
Venous thromboembolism risk in rheumatoid arthritis patients: a systematic review and updated meta-analysis.Eur Rev Med Pharmacol Sci. 2021 Nov;25(22):7005-7013. doi: 10.26355/eurrev_202111_27249. Eur Rev Med Pharmacol Sci. 2021. PMID: 34859863
Cited by
-
Association between glycosylated hemoglobin, diabetes mellitus, and preoperative deep vein thrombosis in patients undergoing total joint arthroplasty: a retrospective study.J Orthop Surg Res. 2022 Sep 29;17(1):430. doi: 10.1186/s13018-022-03328-6. J Orthop Surg Res. 2022. PMID: 36175967 Free PMC article.
-
Pulmonary embolism is more prevalent than deep vein thrombosis in cases of chronic obstructive pulmonary disease and interstitial lung diseases.Springerplus. 2016 Oct 12;5(1):1777. doi: 10.1186/s40064-016-3475-8. eCollection 2016. Springerplus. 2016. PMID: 27795919 Free PMC article.
-
Selection bias in rheumatic disease research.Nat Rev Rheumatol. 2014 Jul;10(7):403-12. doi: 10.1038/nrrheum.2014.36. Epub 2014 Apr 1. Nat Rev Rheumatol. 2014. PMID: 24686510 Free PMC article. Review.
-
A Review of Safety Outcomes from Clinical Trials of Baricitinib in Rheumatology, Dermatology and COVID-19.Adv Ther. 2022 Nov;39(11):4910-4960. doi: 10.1007/s12325-022-02281-4. Epub 2022 Sep 5. Adv Ther. 2022. PMID: 36063279 Free PMC article. Review.
-
Non-Bacterial Thrombotic Endocarditis in a Patient with Rheumatoid Arthritis.Korean Circ J. 2016 May;46(3):425-8. doi: 10.4070/kcj.2016.46.3.425. Epub 2016 Apr 28. Korean Circ J. 2016. PMID: 27275182 Free PMC article.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous